Non-randomized trial of neuromodulation prehabilitation for brain tumor language networks
This is a non-randomized controlled trial from the Prehabilita project (NCT05844605) examining non-invasive neuromodulation-induced prehabilitation (NIP) in 26 patients with operable brain tumors affecting language or motor regions. The study compared language-targeted NIP (11 patients) with NIP targeting non-language networks (14 patients).
The authors report that in the language-targeted group, task-based fMRI revealed reduced overlap between a stimulation target region and fMRI-derived language activation maps. No comparable changes were observed in the control group. The study also found no significant modulation effects in the motor network in either group. Language and cognitive performance were preserved during language network modulation.
Key limitations noted by the authors include the small sample size, non-randomized design, and single-center setting. The study did not report primary outcomes, effect sizes, p-values, or adverse events. Follow-up was assessed before and after prehabilitation.
Practice relevance is restrained; the authors suggest NIP targeting higher-order functions like language may be a safe preoperative strategy to reduce functional constraints on surgery. However, findings are preliminary and require replication in larger, randomized studies.